Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1002/hep.24001
Read article for free, from open access legal sources, via Unpaywall: https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24001
References
Articles referenced by this article (114)
Nonalcoholic fatty liver disease: pathology and pathogenesis.
Annu Rev Pathol, 145-171 2010
MED: 20078219
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Diabetes, (8):1844-1850 2001
MED: 11473047
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
Gastroenterology, (5):1183-1192 2001
MED: 11266382
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.
Hepatology, (2):679-689 2010
MED: 20041406
Long term prognosis of fatty liver: risk of chronic liver disease and death.
Gut, (5):750-755 2004
MED: 15082596
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.
J Hepatol, (1):132-138 2005
MED: 15629518
Long-term follow-up of patients with NAFLD and elevated liver enzymes.
Hepatology, (4):865-873 2006
MED: 17006923
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years.
Gut, (11):1538-1544 2009
MED: 19625277
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.
J Clin Invest, (3):829-838 2008
MED: 18317565
Show 10 more references (10 of 114)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1002/hep.24001
Article citations
Elevated serum growth differentiation factor 15 and decorin predict the fibrotic progression of metabolic dysfunction-associated steatotic liver disease.
Sci Rep, 14(1):27527, 11 Nov 2024
Cited by: 0 articles | PMID: 39528512 | PMCID: PMC11554648
Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression.
Cell Death Dis, 15(10):770, 23 Oct 2024
Cited by: 0 articles | PMID: 39438459 | PMCID: PMC11496806
Characterizing alcohol-related and metabolic dysfunction-associated steatotic liver disease cirrhosis via fibrotic pattern analysis.
Sci Rep, 14(1):23679, 10 Oct 2024
Cited by: 0 articles | PMID: 39390024 | PMCID: PMC11466976
Diagnostic accuracy of exhaled nitric oxide for the non-invasive identification of patients with fibrotic metabolic dysfunction-associated steatohepatitis.
Ann Med, 56(1):2410408, 08 Oct 2024
Cited by: 0 articles | PMID: 39376063 | PMCID: PMC11463020
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.
J Gastroenterol, 59(12):1053-1078, 14 Oct 2024
Cited by: 0 articles | PMID: 39400718
Review
Go to all (1,325) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
[NASH in children].
Nihon Rinsho, 64(6):1168-1172, 01 Jun 2006
Cited by: 1 article | PMID: 16768127
Review
Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Semin Liver Dis, 28(4):407-426, 27 Oct 2008
Cited by: 43 articles | PMID: 18956297
Review
Fatty liver: role of inflammation and fatty acid nutrition.
Prostaglandins Leukot Essent Fatty Acids, 82(4-6):265-271, 02 Mar 2010
Cited by: 50 articles | PMID: 20189787
Review
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Obes Surg, 16(12):1584-1593, 01 Dec 2006
Cited by: 34 articles | PMID: 17217634